HEALTHCARE: San Diego Co. Unveils Painless Glucose Sensor Patch
Biolinq, a medical device company developing a continuous glucose sensor with a novel integrated display on its wearable device, has closed a $100 million Series B financing round led by RiverVest Venture Partners.
BIOTECH: Deal Combines Leading Local Synthetic Biology Firms
Codex DNA (Nasdaq: DNAY) is buying Eton Bioscience, a privately held provider of synthetic biology products and services, for $13 million.
San Diego-based Neurocrine Biosciences (Nasdaq: NBIX) has entered into a strategic collaboration and licensing agreement with Japan’s Sosei Group to develop potential new treatments for schizophrenia, dementia and other neuropsychiatric disorders.
The Next Evolution of Clinical Care
The COVID-19 pandemic has been a trial by fire for hospitals and healthcare providers around the world. And yet, the pandemic has had several silver linings for healthcare organizations.
HEALTHCARE: Facilities Serve Area’s Underserved Patient Populations
San Diego-based Health Center Partners of Southern California (HCP), a regional health care policy advocate for community health centers and underserved patient populations, said 13 of its 17-member health centers earned Community Health Quality Recognition (CHQR) badges for their recent achievements in access to care, quality outcomes, health equity, information technology and contributions to the COVID-19 pandemic response.
MANUFACTURING: Profits Jump 18% Amid Supply Chain Headwinds
San Diego-based ResMed (NASDAQ: RMD) posted strong quarterly results last week, beating analysts’ estimates even as ongoing supply chain bottlenecks slowed delivery and sales of the company’s marketing-leading sleep apnea machines and ventilators used to treat COVID patients.
Halozyme Therapeutics (NASDAQ: HALO) saw a big jump in revenue and record quarterly royalties in Q3. On Tuesday, the San Diego-based biopharmaceutical company posted financial results -- and Wall Street applauded.
San Diego-based Neurocrine Biosciences (NASDAQ: NBIX) reported upbeat Q3 financial results on Monday (Nov. 1), confirming that INGREZZA, the company’s flagship drug that treats tardive dyskinesia, continues to gain market share.
BIOTECH: New Co. Spins Out of Crinetics Pharmaceuticals
Radionetics Oncology, a pharmaceutical company developing radiotherapeutics, launched with $30 million in funding from major life science investors 5AM Ventures and Frazier Healthcare Partners.
For the sixth straight year, Palomar Medical Center Escondido has been named one of America’s 100 Best Hospitals for Orthopedic Surgery, Joint Replacement and Spine Surgery, according to new research released by Healthgrades.
HEALTHCARE: Daniel G. Siegel to Lead Hospital Staffing Services Company
San Diego-based Synergy Health Partners, a hospital and physician staffing services company, has named Daniel G. Siegel as its new chief executive officer.
Consumer-Facing Technologies and Apps Are Digital Tools for Local Providers
Healthcare organizations have transformed their offerings to meet patients where they are at. San Diego healthcare providers are using digital platforms and consumer-facing apps to streamline care options for their patients with everything from scheduling appointments to telehealth visits.
Biotechnology and Biopharmaceutical Companies Delivering New Treatments to Fight Cancer
Among the many segments of life changing work being done in San Diego’s life science community, cancer research has a strong presence.
HEALTHCARE: Hansen Wins Leadership Award
Diane Hansen, president and CEO of Palomar Health won the CEO of the Year award from The Association of California Healthcare Districts for her leadership and transformation of the North County healthcare district.
BIOTECH: Co. Moves Forward in Mexico, Brazil and the Philippines
INOVIO Pharmaceuticals (NASDAQ: INO), a biotechnology company designing DNA medicines, received approval from Mexico’s national health regulatory agency to advance its COVID-19 vaccine candidate to Phase 3 clinical trials.